Login to Your Account



Deal Could Total $859M

NeuroSearch, GSK Expand Drug Development Alliance

By Cormac Sheridan


Wednesday, February 4, 2009
Shares in NeuroSearch A/S rose by almost 7 percent on news that it had expanded its long-standing alliance with GlaxoSmithKline plc, adding new preclinical compounds and potential drug candidates to a portfolio of assets under development. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription